References - Therapeutic Strategies in Cancer Biology and Pathology - page 205

Dai, J., Gu, J., Lu, C., Lin, J., Stewart, D., Chang, D., et al., 2011a. Genetic variations in the
regulator of G-protein signaling genes are associated with survival in late-stage non-
small cell lung cancer. PLoS ONE 6, e21120.
Dai, Y., Xie, C.H., Neis, J.P., Fan, C.Y., Vural, E., Spring, P.M., 2011b. MicroRNA expression
profiles of head and neck squamous cell carcinoma with docetaxel-induced multidrug
resistance. Head Neck J. 33, 786-791.
Davidson, S.D., Cherry, J.P., Choudhury, M.S., Tazaki, H., Mallouh, C., Konno, S., 1999.
Glyoxalase I activity in human prostate cancer. A potential marker and importance in
chemotherapy. J. Urol. 161, 690-691.
Davis, B.N., Hilyard, A.C., Nguyen, P.H., Lagna, G., Hata, A., 2009. Induction of micro-
RNA-221 by platelet-derived growth factor signaling is critical for modulation of vascu-
lar smooth muscle phenotype. J. Biol. Chem. 284, 3728-3738.
Deacon, K., Onion, D., Kumari, R., Watson, S.A., Knox, A.J., 2012. Elevated SP-1 transcription
factor expression and activity drives basal and hypoxia-induced vascular endothelial growth
factor (VEGF) expression in non-small cell lung cancer. J. Biol. Chem. 287, 39967-39981.
Deane, R., Singh, I., Sagare, A.P., Bell, R.D., Ross, N.T., Larue, B., et al., 2012. A multimodal
RAGE-specific inhibitor reduces amyloid beta-mediated brain disorder in a mouse model
of Alzheimer disease. J. Clin. Invest. 122, 1377-1392.
Deans, J.P., Kalt, L., Ledbetter, J.A., Schieven, G.L., Bolen, J.B., Johnson, P., 1995.
Association of 75/80-kDa phosphoproteins and the tyrosine kinases Lyn, Fyn, and Lck
with the B cell molecule CD20. Evidence against involvement of the cytoplasmic regions
of CD20. J. Biol. Chem. 270, 22632-22638.
De Candia, P., Akram, M., Benezra, R., Brogi, E., 2006. Id4 messenger RNA and estrogen
receptor expression: inverse correlation in human normal breast epithelium and carci-
noma. Human Pathol. 37, 1032-1041.
Dechering, K., Boeersma, C., Mosselman, S., 2000. Estrogen receptors alpha and beta: two
receptors of a kind? Curr. Med. Chem. 7, 561-576.
Dehennaut, V., Loison, I., Pinte, S., Leprince, D., 2012. Molecular dissection of the interaction
between HIC1 and SIRT1. Biochem. Biophys. Res. Commun. 421, 384-388.
De Leng, W.W.J., Keller, J.J., Luiten, S., Musler, A.R., Jansen, M., Baas, A.F., et al.,
2005. STRAD in Peutz-Jeghers syndrome and sporadic cancers. J. Clin. Pathol. 58,
1091-1095.
Del Pulgar, T.G., Valdes-Mora, F., Bandres, E., Perez-Palacios, R., Espina, C., Cejas, P., et al.
2008. Cdc42 is highly expressed in colorectal adenocarcinoma and downregulates ID4
through an epigenetic mechanism. Int. J. Oncol. 33, 185-193.
Dessen, P., Le Minor, S., 2002. Updated 2012. Atlas Genet. Cytogenet. Oncol. Haematol.
< http://atlasgeneticsoncology.org/Genes/GC_VASH1.html > .
Decker, S., Zirlik, K., Djebatchie, L., Hartmann, D., Ihorst, G., Schmitt-Graeff, A., et al.,
2012. Trisomy 12 and elevated GLI1 and PTCH1 transcript levels are biomarkers for
Hedgehog-inhibitor responsiveness in CLL. Blood 119, 997-1007.
De Hemptinne, V., Rondas, D., Vandekerckhove, J., Vancompernolle, K., 2007. Tumour necro-
sis factor induces phosphorylation primarily of the nitric-oxide-responsive form of gly-
oxalase I. Biochem. J. 407, 121-128.
De Hemptinne, V., Rondas, D., Toepoel, M., Vancompernolle, K, 2009. Phosphorylation on
Thr-106 and NO-modification of glyoxalase I suppress the TNF-induced transcriptional
activity of NF-kappa B. Mol. Cell. Biochem. 325, 169-178.
Deltour, S., Pinte, S., Guerardel, C., Wasylyk, B., Leprince, D., 2002. The human candidate
tumor suppressor gene HIC1 recruits CtBP through a degenerate GLDLSKK motif. Mol.
Cell. Biol. 22, 4890-4901.